POST FORUM SITE
ATTENDEES
EXHIBITORS
PRESENTERS
INVESTORS
SPONSORS & SUPPORTERS

Confirmed Attending Companies Include:

60 Degrees Pharmaceuticals, LLC
AbbVie, Inc.
Ability Pharmaceuticals, SL
Abingworth LLP
Abzena PLC
Accequa AB
Acesion Pharma ApS
ACOFIMA AG
Acticor Biotech SAS
ACXIT Capital Partners
ADCendo
Addex Therapeutics Ltd.
Adimab, Inc
AdrenoMed AG
Adveq Management
Affimed N.V.
AFFiRiS AG
Agility Health Tech
Aglaia BioMedical Ventures
AIMM Therapeutics BV
Alexion Pharmaceuticals, Inc.
Allecra Therapeutics GmbH
AlloCyte Pharmaceuticals AG
Almirall S.A.
Amorchem
Amryt Pharma
Amtixbio Co., Ltd.
anaBIOsis PC
Anagenesis Biotechnologies
Andrew Keen
ANeuroTech
Anima Biotech Ltd.
Apogenix AG
Aptose Biosciences Inc.
Aravis SA
Arch Therapeutics, Inc.
Arix Bioscience
Arizona State University
Armagen, Inc.
Asklepios SAS
ATGN Consulting
Atlantic Labs
Atriva Therapeutics GmbH
Aurealis Pharma AG
Avicenna Oncology
AWA
AXIM Biotechnologies, Inc.
AYOXXA Biosystems GmbH
B3C Group GmbH
Bachem AG
BAG Healthcare GmbH
Basel Area Swiss
BaselArea Economic Promotion
BaselArea.swiss
BaseLaunch
Bavarian Capital Management
Bellevue Asset Management AG
Belsize Asset Management GmbH
Belvit10
Bergmann zur Hausen & Cie. GmbH
Bio Capital Impact Fund
Bio Medi Gene Ventures
BioBac BioValley Basel Business Angels Club
BIOCRATES Life Sciences AG
Biognosys AG
BioInvent International AB
BioLingus AG
BioMedPartners AG
BiomX
BioNanoSim Ltd.
BioPharma Advisory
BioStart Consulting GmbH
Biotech Alliances International, Inc.
BioVersys AG
Bird & Bird LLP
Boehringer Ingelheim Pharma GmbH
Boehringer Ingelheim Venture Fund  GmbH
Bootstrap Europe
Bpifrance
Breslin AG
Bristol-Myers Squibb
BSD Growth Fund
Caelus Health
Calimmune, Inc.
Camel-IDS NV/SA
Cannabics Pharmaceuticals, Inc.
Cantargia AB
Capital Cell
Capricorn One
Capricorn Venture Partners NV
Cederberg GmbH
Cell Medica
Cellectis SA
Cellestia Biotech AG
Cellply s.r.l.
CenseoVentures LLC
Clarena AG
Clayton Biotechnologies, Inc.
Colpman Consulting Ltd.
Complix NV
Confo Therapeutics
CorAct Advanced Technologies Ltd.
Creathor Ventures
Cukierman & Co. Life Sciences
Cydan Development, Inc.
Cytroreason
Digital Networks PLC
Drooms AG
Dybly AG
E. Gutzwiller & Cie, Banquiers
Eclosion
Economic & Trade Department, Embassy of Israel in Switzerland
Eczacıbaşı Pharmaceutical
Edinburgh Molecular Imaging Ltd.
Edison Group
Edison Investment Research
Edmond de Rothschild Investment Partners
EIT Health e.V.
Ekins Guinness LLP
Elanix Biotechnologies SA
Eli Lilly & Co.
Elthera AG
EMBL Ventures GmbH
EMD Serono
Eminent Venture Capital Corporation / TaiAn Technologies
EP Vantage
Epidarex Capital Management LLP
eTheRNA immunotherapies NV
Euronext

European Investment Bank
European Investment Fund
EVA - the Basel life sciences start-up agency
Evaluate Ltd.
Excellentia Global Partners
Exogenus Therapeutics S.A.
F. Hoffmann-La Roche Ltd.
Fair-Med Healthcare AG
FastVentures B.V.
Forbion Capital Partners
Fraser Finance
FreeMind Group
F-star Biotechnology Ltd.
GB Sciences, Inc.
GeNeuro SA
Geron Corporation
GI Dynamics, Inc.
Gilde Healthcare Partners
GIMV NV
GlaxoSmithKline
Global Life Science Ventures
goetzpartners holding
Grabulovski Consulting Services
Gravitas Capital LLC
Green Cross Cell
GrowthCube Partners, LLC
GSK
Gynotech Ltd.
H. Lundbeck A/S
H.C. Wainwright & Co, Inc.
Hans A. Kuepper
HBM Partners AG
Health Passion Fund
HealthCap
Heidelberg Pharma AG
Heiko Bruhn
Helsinn International Services Sarl
Heptares Therapeutics Ltd.
High-Tech Gruenderfonds Management GmbH
Hoffmann & Co AG
Hookipa Biotech AG
ICF Consult
IGEM Therapeutics Ltd.
Ignite Capital Partners, Inc.
ihang capital
ILTOO Pharma
Imcyse
IMI Consulting GmbH
Immunicum AB
Indelve
Independent
Industrifonden
INKEF Capital BV
Inositec
Instinctif Partners Ltd.
Interceptin
iOnctura
IPD Analytics
IPF Partners
Jacob Waerness
Janssen Business Development
Janssen Pharmaceuticals
Janssen, Pharmaceutical Companies of Johnson & Johnson
JP Morgan Healthcare
Juvabis GmbH
Kanton Basel-Stadt
Karolinska Development AB
Kinled Holding
KOTRA Zürich (Invest Korea)
Kreos Capital Management (UK) Ltd.
Kurma Partners
Labiotech.eu
Leads To Development
LifeCare Partners
LifeSci Advisors
Lipum AB
LMU Munich
LOGSCALE Venture Partners
Lorenza Castellon Consultant
LSP
LSR International BV
Lung Therapeutics, Inc.
Lynx PBV Group
Mamie Capital AG
Manchester Science Partnerships
Mantis Therapeutics
Martina Kaufmann Strategic Consulting
MD1 Management Direct
Medherant Limited
medicxi
Merck KGaA
Merck Ventures B.V.
Mergermarket
Metys Pharmaceuticals AG
Millhouse, LLC
Minoryx Therapeutics S.L.
Mirabaud Securities LLP
MMJ Phytotech Pty Ltd.
Mologen AG
Momentum Biotech
Monitus Research
Morphochem AG
MorphoSys AG
MP Healthcare Venture Management
MPM Capital LP
MRL Ventures Fund
MSD
MTIP
Musli Thyropeutics
Mymetics Corporation
N. Rao Movva
Nanobiotix Corp.
Nanosynex
Nasdaq OMX
NBE-Therapeutics Ltd.
Neomed
New Science Global Healthcare Fund
Nextech Invest Ltd.
NLS Pharma AG
Norgine Ventures Management Limited
Nouscom AG
NOVA SATRA HEALTH Sdn. Bhd.
NovaDiscovery
Novaremed Ltd.
Novartis Institutes for BioMedical Research, Inc.
Novartis International AG
Novartis Pharma AG
Novian Health, Inc.
Novithera

​NovMetaPharma Co., Ltd.
​Novo Holdings A/S
Novo Nordisk A/S
Novo Seeds
NxR Biotechnologies GmbH
Oberland Capital
Obvislim Ltd.
OCT
Omega Funds
Onconova Therapeutics, Inc.
OrbiMed
Origenis GmbH
Oryzon Genomics SA
Otsana Capital
Oxford BioMedica PLC
Paragate Medical
Paul Capital
PDC*line Pharma
Pfizer, Inc.
PharmaBiome AG
Pharmasum Therapeutics AS
PharmaVentures Ltd.
Pharmstandard Ventures
Philimmune, LLC
Philogen S.p.A.
PixCell Medical Ltd.
PM Equity Partner
PMV NV
Positive Capital
Premier Research
Prexton Therapeutics
Primer Capital
PROMETHERA Biosciences S.A./N.V.
Provirex
Pure Communications
Quotient Clinical
Raglan Capital
RBC Capital Markets
RBV Capital
Redalpine Venture Partners
Re-Pharm Ltd.
ResMetrix
RetiCare IVS
Retired
Rhamnopharma
RMI Partners
Roivant Sciences
Rosetta Capital Ltd.
RSA Consulting GmbH
Sachs Associates Ltd.
Salus Partners SA
Sandoz GmbH
Sanofi
Schwarz Financial Communication
Scil Technology  GmbH
Seroba Life Sciences Ltd.
Seventure Partners
Shaw Strategic Capital
Shire Pharmaceuticals
Silence Therapeutics Plc
Silicon Valley Bank
Sirius Healthcare Partners
SIX Swiss Exchange
Societe Generale
Sofinnova Partners
Sophiris Bio, Inc.
SOTIO a.s.
Spencer Stuart
Spherium Biomed
Stifel Financial Corp.
Stratos Bio
Strekin AG
Sunstone Life Science Ventures
SurgiMab S.A.S
SymbioSwiss
Synaffix BV
SynteractHCR
Synthorx
Takeda Pharmaceuticals International GmbH
TargImmune Therapeutics AG
TAXIS Pharmaceuticals, Inc.
Team Côte d'Azur
Techsomed
Telomium, SAS
The Alpine Institute for Drug Discovery
The Bactaviva Project
The Cure BV
The Erler Laboratory
The Fulford Group
ThromboGenics NV
Thuja Capital Management
TL Asset & Interim Management
TolerogenixX GmbH
TOLREMO therapeutics AG
Topadur Pharma AG
Torreya Partners (Europe), LLC
Touchstone Innovations
Transplant Biomedicals SL
Truffle Capital
TVM Capital
TxCell SA
TyrNovo Ltd.
Ulla Brown
uniQure
University Hospital Wuerzburg
University of Strasbourg - LabEx TheraNASH program
UP Biotech Management AG
Valo Therapeutics Ltd.
Valor Management
valuationLAB AG
Vaximm AG
V-Bio Ventures
Venn Therapeutics
Ventac Partners GmbH
Venture Valuation AG / Biotechgate
Verndari, Inc.
Versantis AG
Vesalius Biocapital
VI Partners AG
Vibliome Therapeutics, Inc.
Virility Medical
Vogel BioC
Wellington Partners
Werner Buser
Xeraya Capital
XOventure GmbH
Yorkville Advisors Global, LLC
Ysios Capital Partners
ZFHN